IMAC Holdings price target lowered to $10 from $34.50 at Ascendiant

Ascendiant analyst Edward Woo lowered the firm’s price target on IMAC Holdings to $10 from $34.50 and keeps a Buy rating on the shares. The company’s Q3 reported was “about inline” and its reverse merger with Theralink is on track, the analyst tells investors in a research note.